Arbovax, Inc.

Arbovax, Inc. operates as a clinical stage biotechnology company that develops and commercializes vaccines against arthropod-borne viruses. Its technology is based upon multiple deletions in the transmembrane portion of the virus allowing it to replicate in insect cells, but not in mammalian cells. The company primarily focuses on developing a vaccine technology for the treatment of Chikungunya, a mosquito borne virus. Its technology is also adapted to other mosquito borne viral diseases, such as dengue fever, West Nile, Japanese encephalitis, and yellow fever. The company was founded in 2005 and is based in Raleigh, North Carolina.